Article
Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Feb 2016
Murphy Stephen J, Karnes Robert J, Kosari Farhad, Castellar B Edgardo R Parilla, Kipp Benjamin R, Johnson Sarah H, Terra Simone, Harris Faye R, Halling Geoffrey C, Klein Janet L Schaefer, Nasir Aqsa, Bergstrahl Eric, Rangel Laureano J, Sukov William R, Vasmatzis George, Cheville John C
Abstract excerpt
Patients with clinically insignificant prostate cancer remain a major over-treated population. PTEN loss is one of the most recurrent alterations in prostate cancer associated with an aggressive phenotype, however, the occurrence of PTEN loss in insignificant prostate cancer has not been reported and its role in the separation of insignificant from significant prostate cancer is unclear. An integrated analysis of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
